Verve Ventures is a European venture capital firm and startup investment platform founded in 2010 and based in Switzerland. It operates a fully digital platform that connects early-stage science and technology startups with a network of private and institutional investors, enabling investments from seed to later rounds and supporting portfolio companies with access to talent, client introductions, and expert networks. The portfolio spans energy, computing, robotics, quantum computing, digital health, climate technologies, data analytics, and advanced manufacturing, with a focus on transformative technologies across Europe. Verve Ventures emphasizes rigorous due diligence to identify high-potential opportunities and has built a large community of qualified private investors, family offices, pension funds, and corporates seeking access to European tech ventures. The firm positions itself as a bridge between founders seeking capital and investors seeking exposure to top-tier European startups, aiming to broaden access to otherwise intransparent venture opportunities.

Founded in 2020, the European Innovation Council is a Brussels-based venture capital initiative that supports top innovators, entrepreneurs, small companies, and researchers with bright ideas. It co-invests with private investors in early-stage startups, prioritizes deep technology ventures, and pursues ESG-positive impacts to accelerate commercialization and scale-up.

High-Tech Gründerfonds is a Germany-based venture capital firm established in 2005 that funds early-stage technology startups in Germany. Based in Bonn with an office in Berlin, it supports companies across software, information technology, digital and industrial tech, life sciences, chemistry, IoT, energy, and related fields by providing initial capital and subsequent funding, complemented by active guidance from investment managers. The firm typically acts as a lead investor and cooperates with other investors to help portfolio companies advance from concept to market, with a focus on startups that have begun commercial operations. By combining financing with hands-on support, HTGF aims to help high-potential founders develop their technology, validate products, and scale within the German market.

Redalpine is a Swiss venture capital firm based in Zurich, focused on seed and early-stage investments at the intersection of software and science. It supports portfolio companies with capital, strategic and hands-on operational guidance, and an international network to help scale European startups across technology and health tech sectors. The firm pursues a thesis-driven approach, backing startups from early stages through exit, and leverages a multidisciplinary team of scientists, entrepreneurs, and business leaders to identify opportunities in digital banking, healthcare, industrial automation, biotech, and fintech. Redalpine emphasizes long-term value creation and collaboration with ambitious founders, aiming to transform innovative ideas into scalable businesses.

VI Partners is a Swiss venture capital firm based in Altendorf that specializes in funding healthcare, biotechnology, technology, and software companies across Switzerland and Europe. Founded in 2001, it supports high-growth startups through seed and Series A stages with capital, coaching, and networks, including involvement in university spin-offs. The firm focuses on building lasting value by pairing entrepreneurs with strategic expertise and industry insight to advance innovative companies.

Founderful is a Zurich-based venture capital firm established in 2017 that backs early-stage technology companies in Switzerland. It leads initial investments and provides hands-on support to founders, including board participation, legal guidance, and strategic mentorship to help startups grow, scale, and reach exits. The firm emphasizes a founder-friendly, collaborative approach and leverages a European investor network and a community of founders to foster growth. Its portfolio spans sectors such as software, consumer and business products and services, energy, financial services, and materials, with a focus on Swiss tech ventures. To date, Founderful has backed more than 50 startups and over 120 founders, aiming to help Swiss tech entrepreneurs become global market leaders. Located in Zurich, the firm works with early-stage companies aiming to build lasting companies and achieve successful scale.

Spicehaus Partners is an independent Swiss venture capital firm based in Zug that backs early-stage technology companies in Switzerland, with an emphasis on B2B technology firms; founded in 2018 and owned by its partners, the firm combines investment experience with entrepreneurial expertise and actively supports its portfolio companies to promote growth, aiming to foster long-term partnerships between entrepreneurs and investors.

Tenity is a global innovation ecosystem and early-stage investor dedicated to the future of fintech and related industries. The organization runs two core engines: Innovation Partnerships, which collaborates with corporations and governments to design and operate innovative programs, and Venture Capital, investing in early-stage startups. Through a network of hubs, Tenity connects people, capital, and ideas, delivering funding initiatives, hackathons, accelerators, and market activation programs to startups, corporates, governments, and investors across Europe, Asia, and beyond. Established as a spin-off from SIX in 2016, Tenity has expanded its global footprint and strengthened its presence in the UK through strategic acquisitions. It focuses on fintech, insurtech, Web3, and digital health, with activities spanning Europe, the Middle East and Africa, and APAC regions.

b2venture is a European venture capital firm that supports early-stage technology companies with a focus on digital and industrial tech. Based in Saint Gallen, Switzerland, the firm operates across Europe and leverages a network of angel investors to back startups from pre-seed to Series A; typical investments range from 0.25 to 3.5 million euros, accompanied by strategic guidance and ongoing support to help portfolio companies scale. Sectors of interest include AI, fintech, healthcare, education, cybersecurity, information technology, e-commerce, digital health, and SaaS, spanning both B2B and consumer-facing technologies. The firm aims to foster innovation by helping ambitious founders reach key milestones and grow within the European ecosystem.

CV VC is a venture capital firm focused on seed to growth investments in blockchain, crypto and AI-enabled startups, with global reach across Europe, the United States, and the Middle East. The firm supports portfolio companies through its ecosystem arm, CV Labs, which offers acceleration programs, summits, coworking spaces, private offices, mentorship, and access to funding and industry expertise. CV VC covers critical startup stages including business model development, technology assessment and token economics, communication strategy, and attracting capital and strategic partnerships. The organization positions itself as a blockchain advisory resource within Crypto Valley, helping startups, corporates, and investors leverage AI and blockchain technologies. To date CV VC has made numerous investments, building a diverse ecosystem that bridges founders with capital, strategic partners, and ecosystem services.

Serpentine Ventures is a Swiss venture asset management firm that serves as the investment arm of Swiss Ventures Group. Based in Zurich, it concentrates on venture investments in information technology and software as a service, with a focus on European markets. The firm backs early- and growth-stage startups, including deep tech and climate tech, leveraging a broad network and market expertise to support companies from inception through scale. It operates as a subsidiary of Swiss Ventures Group and provides advisory services for multiple funds, offering tailored access to venture capital for high net worth individuals, professionals, and institutions.

Bloomhaus Ventures is a Swiss-based venture capital firm and the venture arm of a Swiss family office. It backs early-stage B2B startups across Europe, with emphasis on the DACH region, in Industrytech, Deeptech (AI, IoT, robotics, blockchain, cybersecurity), and CleanTech. The firm typically supports pre-seed and seed rounds, providing capital and practical assistance such as business strategy, go-to-market and market-entry guidance to help portfolio companies scale. It maintains an international reach, including Switzerland and broader European markets, and seeks long-term partnerships that enable sustainable growth.

Alpana Ventures is a Swiss venture capital firm focused on digital transformation and early-stage deep tech, founded in 2016 and headquartered in Geneva with offices in Paris, Saratoga (California) and Sierre. The firm supports founder teams across Switzerland, Europe and the United States, investing across seed, early stage, Series A/B and growth capital. Its scope covers healthcare, information technology, finance, enterprise solutions, mobility, social media, gaming and cybersecurity, and it emphasizes embedding portfolio companies into innovative business models to become global market leaders. Guided by ESG criteria, Alpana Ventures seeks to contribute to a more sustainable future.

Merck is a German science and technology company based in Darmstadt. Founded in 1668, it operates three main business areas: Life Science, which provides laboratory consumables and instruments for researchers; Electronics, which offers specialty materials for manufacturing semiconductors and displays; and Healthcare, which develops and sells branded pharmaceuticals with significant concentrations in oncology, neurology and fertility, supported by patient devices and digital health solutions. The company serves customers worldwide across Europe, Africa, Asia, Oceania and Latin America. Historically, the business is distinct from Merck & Co. in the United States and Canada, which operates under a different name in those markets. Merck is one of the oldest operating chemical and pharmaceutical companies.

TX Ventures is the corporate venture arm of TX Group, based in Zurich, Switzerland. It manages a CHF 100 million fund focused on investing in fintech, insurtech, proptech, cybertech, and digital assets across Europe, including the UK. Beyond capital, TX Ventures provides strategic guidance, access to customers, and hands-on support in marketing, technology, and IT security to portfolio companies, and typically targets seed to Series A rounds of CHF 1-5 million. Portfolio companies include Sinpex, Cashlink, and Trustap.

EquityPitcher Ventures is a Zurich-based venture capital firm founded in 2016 that invests in seed-stage B2B technology companies across the DACH region. The firm leverages a broad industry network to accelerate B2B software and technology sales and pursues a diversified investment approach across sectors including digital health, ICT, and finance, supporting startups to scale within Switzerland and beyond.

ACE & Company is a private equity and venture capital firm established in 2005 and based in Geneva, Switzerland, with offices in London, Cairo, Hong Kong and New York. The firm invests globally across private markets and engages in angel, growth, early, mature, buyout and secondary transactions, often taking leading or co-investment roles at multiple stages. It maintains a sector- and region-agnostic approach while pursuing opportunities in healthcare services, information technology, financial services, energy services, business products and services, as well as consumer goods and technology. ACE emphasizes diversified portfolios and risk management by sizing investments to the risk profile and tailoring exposure to a company’s development stage, seeking long-term, sustainable returns. Through specialized investment teams, it aims to provide flexible, long-term capital and strategic support to portfolio companies across its global footprint.

Kickfund is a Swiss venture capital firm that invests in deep-tech startups emerging from Swiss academic institutions. It partners with the Venture Kick competition and co-invests up to CHF 850,000 to support early-stage companies, providing strategic guidance and access to a diverse network of mentors and investors. Backed by the Ernst Göhner and Gebert Rüf Foundations, Kickfund aims to strengthen Switzerland’s innovation ecosystem and establish the country as a global hub for deep tech, digital, and life sciences. The firm operates with a systematic investment approach and maintains a portfolio across high-potential ventures, emphasizing scalable solutions and impact.

FiveT Group is a Swiss investment holding company established in 2006 that builds a diversified portfolio across energy, digitization of financial services, technology, and life sciences to deliver impact through strategic investments and partnerships. The group operates through subsidiaries including FiveT Fintech, the venture capital arm founded in 2018 that backs fintech and healthcare startups developing technologies such as blockchain and machine learning, and FiveT Capital, an asset management arm licensed to offer asset management services in Switzerland, specializing in equity linked funds and tailored hedging solutions with a focus on sectors such as nuclear, cleantech, and life sciences in public markets.

HBM Healthcare Investments is a Swiss investment firm founded in 2001 that focuses on delivering access to a globally diversified portfolio of healthcare companies. Headquartered in Switzerland, the firm targets opportunities across human medicine, biotechnology, medical technology and diagnostics, investing in both private and public companies with established or near-market products. It emphasizes active portfolio management and provides strategic guidance to portfolio companies to support value creation. By leveraging demographic trends and medical innovation, the firm seeks attractive returns while maintaining a diversified asset mix that includes private holdings, public equities and funds. The company is noted for an attractive dividend policy with a yield around five percent.

BioMedPartners is a Switzerland-headquartered venture capital firm focused on life sciences. It targets early- and mid-stage investments in healthcare and human life science companies, including pharmaceuticals, biotechnology, diagnostics and medical technology, with activity across Central Europe and offices in Germany and Guernsey.

SIX FinTech Ventures is the corporate venture capital arm of SIX Group, based in Zurich, Switzerland. It invests in global early-stage fintech startups from seed to Series A, focusing on wealth management, capital markets, RegTech, and token ecosystems, and leveraging technologies such as blockchain, artificial intelligence, big data, IoT, and AR/VR. The firm targets opportunities in Switzerland, Western Europe, and opportunistically in other regions, with initial tickets typically ranging from CHF 0.2 to 3 million.

Privilège Ventures is a Swiss-based venture capital firm authorized by the Swiss Financial Market Supervisory Authority as a venture capital asset manager. Headquartered in Lugano with offices in Zurich and Boston, it invests in early-stage startups across Europe from pre-seed to Series A, with a focus on HealthTech, CleanTech and AgriFoodTech. The firm provides strategic guidance, industry expertise and access to a broad network to support founders, drawing on a team with deep financial and operational experience to foster growth and long-term value creation.

Founded in Zurich, Switzerland, Wingman Ventures is a venture capital firm focusing on early-stage investments within the information technology sector.

Gimv is a European investment company established in 1980 and based in Antwerp, Belgium. It specializes in private equity and venture capital, backing companies across consumer, food, wellbeing, healthcare, life sciences, smart industries, energy, electrification, digitalisation and automation, and sustainable cities. Gimv manages investments in a diversified portfolio of companies, with around 85 portfolio companies generating more than EUR 6 billion in combined turnover and employing over 28,000 people. The firm oversees approximately EUR 1.8 billion of investments, including third-party funds. It operates across multiple European markets, including France, Germany, Belgium, the Netherlands, Luxembourg, Austria and Switzerland.

BackBone Ventures is an early-stage venture capital firm founded in 2018 and headquartered in Zurich and Frankfurt am Main. It targets seed and start-up investments in information and communication technology, food technology, and disruptive technologies across the DACH region and Israel, with activity in Germany, Switzerland, Austria, and Israel. The firm supports founders at pre-seed and seed stages and aims to be a trusted partner for both founders and co-investors, prioritizing high-potential teams that tackle large markets and, where possible, founders who have overcome structural barriers. It pursues a hands-on ecosystem approach to back ventures across various industries, seeking positive impact for the next generation.

Pfizer is a global pharmaceutical company that develops, manufactures, and sells medicines and vaccines across a broad range of therapeutic areas. It aims to provide safe, effective, and affordable health care solutions and services that support wellness, prevention, and treatment. The company maintains a substantial portfolio of prescription medicines and vaccines and pursues a robust pipeline of new products and technologies intended to address major diseases, including cancer and neurodegenerative conditions. Pfizer conducts business worldwide, with a significant share of international sales and a broad geographic footprint. Founded in 1849 and headquartered in the United States, Pfizer focuses on research and development, manufacturing scale, and strategic collaborations to improve patient outcomes and expand access to therapies.

Global Founders Capital is a Berlin-based venture capital platform founded by Rocket Internet that invests in early-stage technology companies worldwide. It operates as a globally oriented, stage-agnostic investor, partnering with exceptional founders across sectors and providing support from the initial growth phase through scale. The firm targets high-potential, rapidly expanding ventures and emphasizes impact and feasibility in evaluating opportunities. It is led by investment partners Cedric Asselman, David Sainteff, and Fabricio Pettena.

seed + speed Ventures is a venture capital firm that focuses on seed investments in B2B software startups. It has offices in Berlin, Munich, Hanover, and San Francisco and is part of the Maschmeyer Group. The firm backs pre-seed to seed-stage B2B software companies in Germany, Switzerland, and Austria. It provides equity investments and sales support to portfolio companies. Typical ticket sizes range from EUR 50,000 to EUR 500,000, with follow-on funding available up to EUR 1 million. Founded in 2016, the firm concentrates on early-stage software companies in the DACH region.

Wille Finance is a Swiss-based family office and investment platform established in 2007. Based in Zug, it provides tailored wealth management and makes direct investments across private equity, venture capital and buyouts, real estate, and listed assets, aiming for long-term value creation. The firm emphasizes an entrepreneurial approach and close client relationships, with governance managed by an executive team. It is described as a Swiss-based family office and investment platform that combines private market and liquid investments for sophisticated clients.

Forestay Capital is an early-growth venture capital firm focusing on enterprise software, artificial intelligence, and data-driven technology. It provides growth capital to revenue-generating companies at inflection points, supporting them from early revenue stages to market leadership. The firm targets enterprise AI, SaaS, data infrastructure, cybersecurity, productivity, and automation sectors across Europe, Israel, and the East Coast of the United States. It operates with offices in London and Geneva and is part of the B-FLEXION group. Forestay emphasizes rigorous due diligence and adds value from day one, leveraging sector expertise to help portfolio companies scale within five years.

Lakestar is a Swiss venture capital firm headquartered in Zurich, with offices in Berlin and London, investing in technology companies across Europe and the United States. The firm backs startups from seed to growth stages and helps portfolio companies expand into new markets with support in business development, technology, recruitment, and marketing. Its investments span deep tech, artificial intelligence, fintech, healthcare, and digitalization, with a track record that includes early stakes in Spotify, Skype, Facebook, and Airbnb. Lakestar emphasizes collaboration with exceptional entrepreneurs and seeks to identify companies with potential to redefine sectors and create lasting value.

Founded in 2017, DART Ventures is a Swiss venture capital firm investing in breakthrough technologies that positively impact health and climate. The company focuses on B2B, healthtech, foodtech, clean tech, and climate tech sectors across the U.S. and Europe. DART's unique approach includes a 12-month expansion program for startups, providing strategic guidance and access to experienced partners.

DIventures is a venture capital firm that supports and accelerates FinTech and RegTech innovations and trends.

DAA Capital Partners is a Geneva-based venture capital firm founded in 2018. It invests in early-stage and later-stage technology companies across Europe, with a focus on France, Germany, and Switzerland. The firm targets business-to-business and technology-driven sectors, including information technology, e-commerce, software as a service, manufacturing, Internet of Things, augmented reality, artificial intelligence, machine learning, big data, and real estate technology, and it also backs firms in automation and immersive technologies.

Invision is a Switzerland-based private equity firm with a base in Zug and offices in Germany that focuses on buyouts and growth investments in Europe. Founded in 1997, it has backed more than 60 companies to date, aiming to help them grow and deliver returns to their owners and stakeholders. The firm targets growth-oriented mid-market businesses across sectors including information technology, software, healthcare and medical technology, education, consumer and luxury goods, e-commerce, and industrial services, with a particular emphasis on German-speaking Europe. It maintains affiliates such as Invision Asset Management and Link Marketing Services to support its investment activities.

Nivalis Group is a venture capital firm based in Villaz-Saint-Pierre, Switzerland, founded in 2002. The firm focuses on investing in early-stage, seed, and series A startups that operate within the fields of automation, robotics, additive manufacturing, and artificial intelligence. Nivalis Group aims to create a supportive environment for these high-tech startups, facilitating innovation and the development of unique products and technologies. By promoting synergies and encouraging collaborative interactions among its portfolio companies, Nivalis Group fosters growth and aims to nurture successful and profitable businesses.

OCCIDENT is an owner-managed venture capital firm that invests in deep tech start-ups, focusing on spin-offs from scientific research to enable real-world solutions. With offices in Munich and Zug, it supports early-stage companies in life sciences and industrial tech, and accompanies portfolio companies over the long term with financial backing and extensive operating experience. The firm invests its own money and makes decisions based on sustainable potential for success, aiming to contribute positively to society in a sustainable way. OCCIDENT collaborates closely with founding teams to tackle challenges, foster innovation, and drive long-term impact.

Bernina BioInvest is a venture capital firm founded in 2019 and based in Zug, Switzerland, focusing on early-stage investments in biotechnology and medical technology sectors.

Clima Now is a venture capital firm based in Zurich, Switzerland, founded in 2021. It backs early-stage startups focused on climate tech and the green energy transition, including carbon capture, carbon dioxide removal, food safety, and agtech. The firm supports solutions that reduce greenhouse gas emissions and advance climate protection, aiming for scalable ventures with meaningful environmental and economic impact.

L1D is a venture capital firm based in Zurich, Switzerland, focusing on digital assets, cryptocurrency, and blockchain technology sectors. Founded in 2018, the firm pursues opportunities in the blockchain ecosystem and utilizes a multi-strategy approach that includes event-driven, long/short, and fundamental equity strategies to assess value and manage risk.

Exelixis Capital is a venture capital firm based in Zurich, Switzerland. Founded in 2021, it seeks to invest in longevity, circular economy, and exponential technologies.

Planven Entrepreneur Ventures is a venture capital firm founded in 2018 and based in Zurich, Switzerland. It invests in European technology companies spanning artificial intelligence, big data, software-as-a-service, cybersecurity, and health technology, with a focus on fast-growing B2B markets. The firm emphasizes a rigorous due diligence approach and proprietary deal sourcing to identify high-potential opportunities.

Vine Ventures is a venture capital firm based in Zurich, Switzerland, founded in 2019. It focuses on exploring unique business models in the life sciences sector and was established by founding General Partner Ryan Zurrer.

Brainforest is an impact venture studio and accelerator based in Zurich, Switzerland. Founded in 2019, it supports ventures addressing forests, climate change, agriculture, biodiversity, and health by providing financial backing and programmatic support to help scale innovative solutions.

āltitude is a pan-European early-stage venture capital firm with bases in Berlin and offices in London and Zurich. It makes pre-seed and seed investments in startups that accelerate the digital transformation of small and medium-sized enterprises, with a focus on SME tech across Europe. The firm supports startups to drive efficiency and growth for SMEs through digital solutions and has launched SME Tech Leaders, a community for founders and operators building digital solutions for European SMEs.

Lurra Capital is a Switzerland-based private capital investment firm established in 2017 and led by Tyron Birkmeir. It serves ultra-high-net-worth investors and family offices by providing access to strategic, alternative opportunities across three core areas: real estate, private equity, and venture capital. The firm is headquartered in Zurich with additional offices in Luxembourg and Monaco, and it oversees approximately $5 billion in assets under management. Its real estate activity focuses on the acquisition, development, and management of residential assets, including multi-family properties, with a geographic emphasis on Switzerland and Florida. Through its private equity and venture units, it backs growth-stage and innovative companies across diversified sectors. The company operates as an invitation-only partner for sophisticated investors seeking diversified exposure to private markets.

TiVenture is a venture capital firm based in Lugano, Switzerland that funds and supports early-stage technology companies, with focus on life sciences, medical, high-tech, and IT sectors. The firm pursues high-growth opportunities, emphasizing innovative technologies with global market potential and a diversified portfolio primarily in southern Switzerland. It actively seeks exceptional founders and scalable products, providing capital and guidance to help early-stage companies develop, validate, and scale their products for international markets.

Versant Ventures is a healthcare-focused venture capital firm founded in 1999 and headquartered in San Francisco, with offices in Canada, the United States, and Europe. The firm invests across the healthcare sector at all stages, with emphasis on the discovery and development of novel therapeutics, including pharmaceuticals, biotechnology, medical devices, and life sciences. Versant combines investment, operating, and scientific expertise to support portfolio companies through strategic guidance and hands-on involvement in company building. The firm manages substantial capital, enabling a hands-on approach to helping entrepreneurs build durable companies addressing high unmet medical needs.

Endeavour Vision is a global investment firm dedicated to fostering advancements in healthcare through strategic investments in transformative technologies, focusing on medical devices and digital health. It provides not only capital but also strategic and regulatory support to help portfolio companies scale in Europe and North America, with an emphasis on delivering financial and social returns. The firm leverages a broad international network and deep sector expertise to support commercial strategy, regulatory submissions, and market access. It has a track record of successful exits including Vertiflex, Medartis, and Symetis, and maintains offices in Geneva, Switzerland and Minneapolis, United States.